SCHEMBL1662718

SCHEMBL1662718

COc1cc(Cc2ccc3ccccc3c2)nc2n[nH]c(C3=CC=C3)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
PDE10A Q9Y233 7/20 0.39
CETP P11597 1/20 0.39
BACE1 P56817 1/20 0.36
DAO P14920 1/20 0.36
MPO P05164 1/20 0.35
NPY5R Q15761 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2A6 P11509 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
PRKDC P78527 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1662715 0.77 PDE10A (0.40) ADORA2AADORA1PDE10ACETPBACE1
SCHEMBL1662466 0.67 ADORA1 (0.37) ADORA2AADORA1PDE10ABACE1DAO
SCHEMBL25798810 0.62 PDE10A (0.59) PDE10ACETPCYP1A2CYP2A6MEN1
SCHEMBL9634809 0.60 LTA4H (0.68) ADORA2AADORA1PDE10ACETPLMNA
SCHEMBL2838141 0.58 CYP1A2 (0.65) CYP1A2CYP2A6KMT2A
SCHEMBL19087103 0.58 CETP (0.55) ADORA2AADORA1PDE10ACETPMAPT
SCHEMBL10434818 0.57 APP (0.60) CETPMAPTCYP1A2CYP2A6
SCHEMBL28247152 0.57 CYP2D6 (0.46) ADORA2AADORA1PDE10ACETPMPO
SCHEMBL21690568 0.57 PDE10A (0.76) PDE10ALMNAMAPTCYP1A2MEN1
SCHEMBL16788291 0.57 PDE10A (1.00) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120220624-A1 PYRAZOLO [3,4-B] PYRIDIN-4-ONE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2012-08-30 US disclosed
EP-2490693-A1 PYRAZOLO [3,4-b]PYRIDIN-4-ONE KINASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2012-08-29 EP disclosed
WO-2011049722-A1 PYRAZOLO [3,4-b] PYRIDIN-4-ONE KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220624-A1 PYRAZOLO [3,4-B] PYRIDIN-4-ONE KINASE INHIBITORS CDK1, CDK5, TTBK1 ADORA2A 3006/4885ADORA1 2411/4885PDE10A 1231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.